The use of fluor-hydroxy pulse peel in actinic porokeratosis

Dermatologic Surgery

Volumn 31, Issue 9 PART 1, 2005, Pages 1145-1148

  Teixeira, Solange P ^a,b   De Nascimento, Maurício M ^a   Bagatin, Ediléia ^a   Hassun, Karime M ^a   Talarico, Sérgio ^a   Michalany, Nilceo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GLYCOLIC ACID; RETINOIC ACID; SALICYLIC ACID; GLYCOLIC ACID DERIVATIVE; KERATOLYTIC AGENT;

ACTINIC KERATOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG TOLERANCE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT OUTCOME; BIOPSY; ESTHETIC SURGERY; FEMALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POROKERATOSIS; SKIN; ULTRAVIOLET RADIATION;

BIOPSY; CHEMEXFOLIATION; FEMALE; FLUOROURACIL; GLYCOLATES; HUMANS; KERATOLYTIC AGENTS; MIDDLE AGED; POROKERATOSIS; SKIN; ULTRAVIOLET RAYS;

EID: 26944502041     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2005.31913     Document Type: Article

References (29)

1. Alen AL, Glaser DA. Disseminated actinic porokeratosis associated with topical PUVA. J Am Acad Dermatol 2000;43:720-2.
2. Spencer L. e-Medicine instant access to the minds of medicine- porokeratosis: article by Linda V. Spencer, MD. Nov 2003. Available at: http://www.emedicine.com (accessed Jul 9, 2004).
3. MacKie RM. Epidermal skin tumors. In: Champion RH, Burton JL, Ebling FJG, editors. Textbook of dermatology. 5th ed. Oxford (UK): Blackwell Scientific Publications; 1992. p. 1480-1.
4. Katz BE. The Fluor-Hydroxy pulse peel: a pilot evaluation of new superficial chemical peel. Cosmet Dermatol 1995;8:24-30.
5. Marrero GM Katz BE. The new Fluor-Hydroxy pulse peel. Dermatol Surg 1998;24:973-8.
6. Schmack SP, Commens CA. Disseminated actinic porokeratosis: a clinical study. J Am Acad Dermatol 1989;20:1015-8.
7. Leow YH, Soon YH, Tham SN. A report of 31 cases of porokeratosis at the National Skin Centre. Ann Acad Med Singapore 1996;25:837-41.
8. Xia JH, Yang YF, Deng H, et al. Identification of locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. J Invest Dermatol 2000;114:1071-4.
9. Sasson M, Krain AD. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 1996;22:339-42.
10. Sawai T, Hayakawa H, Danno K, et al. Squamous cell carcinoma arising from giant porokeratosis: a case with extensive metastasis and hypercalcemia. J Am Acad Dermatol 1996;34:507-9.
11. Gray MH, Smoller BS, McNutt NS. Carcinogenesis in porokeratosis. Evidence for a role relating to chronic growth activation of keratinocytes. Am J Dermatopathol 1991;13:438-44.
12. Magee JW, McCalmont TH, Leboit PE. Overexpression of p53 tumor suppressor protein porokeratosis. Arch Dermatol 1994;130:187-90.
13. Ninomiya Y, Urano Y, Yoshimoto K, et al. p53 gene mutation in porokeratosis and porokeratosis associated squamous cell carcinoma. J Dermatol Sci 1997;14:173-8.
14. Shelley WB, Shelley ED. Disseminated superficail porokeratosis: rapid therapeutic response with fluorouracil. Cutis 1983;32:139-40.
15. Sander CA, Pfieffer C, Kligman AM, Plewig G. Chemotherapy for disseminated actinic ketarosis with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 1997;36(2 Pt 1):236-8.
16. Nahm WK, Danahy JF, Badiavas E, Falanga V. Systemic 5-fluorouracil producing an inflammatory response porokeratosis. J Eur Acad Venereol 2003;17:190-2.
17. Wolff-Schreiner EC. Porokeratosis. In: Fitzpatrick T, Eisen A, Wolff K, et al, editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1992. p. 566-9.
18. Böhm M, Luger TA, Bonsmann G. Disseminated superficial porokeratosis: treatment with topical tacalcitol. J Am Acad Dermatol 1999;40:470-80.
19. Thiers BH. The use of topical calcipotriene/calcipocitrol in conditions other than plaque psoriasis. J Am Acad Dermatol 1997;37 (Suppl 3 Pt 2):S69-71.
20. Berman B, Poochareon VN, Villa AM. Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin Ther Lett 2002;7(9):1-6.
21. Schwartz T, Seiser A, Gschnait F. Disseminated superficial "actinic" porokeratosis. J Am Acad Dermatol 1984;11:724-30.
22. Nayeemuddin FA, Wong M, Yell J, Rhodes LE. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol 2002;27:703-6.
23. Monheit GD. Consultation for photoaging skin. Dermatol Clin 2001;19:401-3.
24. Jeffes EW III, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol 2000;1:167-79.
25. Monheit GD. The Jessner's + TCA peel: a medium-depth chemical peel. J Dermatol Surg Oncol 1989;15:945-50.
26. Lawrence N, Cox SE, Cockerell CJ, et al. A comparison of the efficacy and safety of Jessner solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 1995;131:176-81.
27. Monheit GD. Medium-depth chemical peels. Dermatol Clin 2001;19:413-25.
28. Monheit GD. Chemical peels. Skin Ther Lett 2004;9(2):6-11.
29. Bercovitch L. Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-fluorouracil: a double-bind controlled study. Br J Dermatol 1987;116:549-52.